Medicare Part D Drug Coverage List

According to the Centers for Medicare & Medicaid Services (CMS) 2026 Part D formulary data, this list covers 6,046 drugs across Medicare Part D plans, sorted by how broadly each is covered. Under the Inflation Reduction Act, Part D out-of-pocket costs are capped at $2,000 a year in 2026; see our methodology for how coverage breadth is calculated.

Coverage varies by plan and geography. Verify drug coverage with your specific plan before making decisions.

Overview Browse Drugs Part D Plans Rankings

Drug Name	Plans Covering	Coverage %	Avg Tier	PA %	2023 Benes
trazodone hydrochloride 300 MG Oral Tablet trazodone hydrochloride	3,792	74.8%	T2	0%	3,666,058
Emollient fluocinonide 0.5 MG/ML Topical Cream Emollient fluocinonide	3,770	74.4%	T3	0%	-
desloratadine 5 MG Oral Tablet desloratadine	3,768	74.4%	T2	0%	42,939
Once-Daily clindamycin 0.01 MG/MG Topical Gel Once-Daily clindamycin	3,761	74.2%	T2	21.3%	-
{28 (estradiol 1 MG / norethindrone acetate 0.5 MG Oral Tablet) } Pack estradiol	3,758	74.2%	T3	12.2%	-
amiodarone hydrochloride 400 MG Oral Tablet [Pacerone] amiodarone hydrochloride	3,756	74.1%	T3	0%	797,134
1 ML secukinumab 150 MG/ML Auto-Injector [Cosentyx] secukinumab	3,756	74.1%	T4	98.5%	-
1 ML secukinumab 150 MG/ML Prefilled Syringe [Cosentyx] secukinumab	3,756	74.1%	T4	98.5%	-
0.5 ML secukinumab 150 MG/ML Prefilled Syringe [Cosentyx] secukinumab	3,756	74.1%	T4	98.5%	-
2 ML secukinumab 150 MG/ML Auto-Injector [Cosentyx] secukinumab	3,756	74.1%	T4	98.5%	-
atogepant 60 MG Oral Tablet [Qulipta] atogepant	3,755	74.1%	T3	98.1%	25,190
atogepant 10 MG Oral Tablet [Qulipta] atogepant	3,755	74.1%	T3	98.1%	25,190
atogepant 30 MG Oral Tablet [Qulipta] atogepant	3,755	74.1%	T3	98.1%	25,190
250 ML soybean oil 200 MG/ML Injection [Intralipid] soybean oil	3,754	74.1%	T3	99.1%	51
hydrocortisone 10 MG/ML Topical Cream [Ala-Cort] hydrocortisone	3,753	74.1%	T2	0%	1,257,661
lubiprostone 0.008 MG Oral Capsule lubiprostone	3,747	73.9%	T3	0%	86,240
lubiprostone 0.024 MG Oral Capsule lubiprostone	3,747	73.9%	T3	0%	86,240
colesevelam hydrochloride 625 MG Oral Tablet colesevelam hydrochloride	3,743	73.9%	T3	0%	66,749
rabeprazole sodium 20 MG Delayed Release Oral Tablet rabeprazole sodium	3,736	73.7%	T2	0%	65,972
azelaic acid 0.15 MG/MG Topical Gel azelaic acid	3,734	73.7%	T3	0%	37,203
levonorgestrel 0.000813 MG/HR Intrauterine System [Liletta] levonorgestrel	3,731	73.6%	T3	0.7%	650
1 ML ustekinumab-kfce 90 MG/ML Prefilled Syringe [Yesintek] ustekinumab-kfce	3,726	73.5%	T4	98.2%	-
fidaxomicin 200 MG Oral Tablet [Dificid] fidaxomicin	3,725	73.5%	T4	23.2%	21,562
60 ACTUAT tiotropium 0.0025 MG/ACTUAT Inhalation Spray [Spiriva]	3,723	73.5%	T3	1.3%	-
isosorbide mononitrate 10 MG Oral Tablet isosorbide mononitrate	3,721	73.4%	T2	0%	1,121,415
isosorbide mononitrate 20 MG Oral Tablet isosorbide mononitrate	3,721	73.4%	T2	0%	1,121,415
dimethyl fumarate 120 MG Delayed Release Oral Capsule dimethyl fumarate	3,712	73.3%	T3	76.4%	7,901
dimethyl fumarate 240 MG Delayed Release Oral Capsule dimethyl fumarate	3,712	73.3%	T3	76.4%	7,901
{28 (ethinyl estradiol 0.02 MG / levonorgestrel 0.09 MG Oral Tablet) } Pack ethinyl estradiol	3,710	73.2%	T2	0%	-
{28 (estradiol 0.5 MG / norethindrone acetate 0.1 MG Oral Tablet) } Pack estradiol	3,705	73.1%	T2	12.8%	-
amantadine hydrochloride 100 MG Oral Tablet amantadine hydrochloride	3,695	72.9%	T2	0%	98,048
bacitracin 0.5 UNT/MG / polymyxin B 10 UNT/MG Ophthalmic Ointment [Polycin] bacitracin	3,694	72.9%	T2	0%	14,794
{14 (dimethyl fumarate 120 MG Delayed Release Oral Capsule) / 46 (dimethyl fumarate 240 MG Delayed Release Oral Capsule) } Pack dimethyl fumarate	3,691	72.8%	T3	77.9%	-
{28 (estradiol 1 MG / norethindrone acetate 0.5 MG Oral Tablet) } Pack [Abigale 1/0.5 28 Day] estradiol	3,685	72.7%	T3	11.9%	-
0.5 ML benralizumab 20 MG/ML Prefilled Syringe [Fasenra] benralizumab	3,683	72.7%	T4	100%	2,747
naproxen sodium 550 MG Oral Tablet naproxen sodium	3,680	72.6%	T2	0%	39,316
0.5 ML fondaparinux sodium 5 MG/ML Prefilled Syringe fondaparinux sodium	3,678	72.6%	T3	0%	-
0.4 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe fondaparinux sodium	3,678	72.6%	T4	0%	-
0.6 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe fondaparinux sodium	3,678	72.6%	T4	0%	-
0.8 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe fondaparinux sodium	3,678	72.6%	T4	0%	-
promethazine hydrochloride 1.25 MG/ML Oral Solution promethazine hydrochloride	3,677	72.6%	T2	56.8%	523,738
24 HR deutetrabenazine 6 MG Extended Release Oral Tablet [Austedo] deutetrabenazine	3,674	72.5%	T4	99.7%	18,283
24 HR deutetrabenazine 12 MG Extended Release Oral Tablet [Austedo] deutetrabenazine	3,674	72.5%	T4	99.7%	18,283
24 HR deutetrabenazine 24 MG Extended Release Oral Tablet [Austedo] deutetrabenazine	3,674	72.5%	T4	99.7%	18,283
24 HR deutetrabenazine 30 MG Extended Release Oral Tablet [Austedo] deutetrabenazine	3,674	72.5%	T4	99.7%	18,283
24 HR deutetrabenazine 36 MG Extended Release Oral Tablet [Austedo] deutetrabenazine	3,674	72.5%	T4	99.7%	18,283
24 HR deutetrabenazine 42 MG Extended Release Oral Tablet [Austedo] deutetrabenazine	3,674	72.5%	T4	99.7%	18,283
24 HR deutetrabenazine 48 MG Extended Release Oral Tablet [Austedo] deutetrabenazine	3,674	72.5%	T4	99.7%	18,283
24 HR deutetrabenazine 18 MG Extended Release Oral Tablet [Austedo] deutetrabenazine	3,674	72.5%	T4	99.7%	18,283
{28 (estradiol 1 MG / norethindrone acetate 0.5 MG Oral Tablet) } Pack [Mimvey] estradiol	3,669	72.4%	T3	11.9%	1,302
168 HR buprenorphine 0.005 MG/HR Transdermal System buprenorphine	3,662	72.3%	T3	34.4%	-
168 HR buprenorphine 0.01 MG/HR Transdermal System buprenorphine	3,662	72.3%	T3	34.4%	-
168 HR buprenorphine 0.015 MG/HR Transdermal System buprenorphine	3,662	72.3%	T3	34.4%	-
168 HR buprenorphine 0.02 MG/HR Transdermal System buprenorphine	3,662	72.3%	T3	34.4%	-
168 HR buprenorphine 0.0075 MG/HR Transdermal System buprenorphine	3,662	72.3%	T3	34.4%	-
donepezil hydrochloride 23 MG Oral Tablet donepezil hydrochloride	3,661	72.3%	T2	0%	1,468,151
{7 (24 HR deutetrabenazine 12 MG Extended Release Oral Tablet [Austedo]) / 7 (24 HR deutetrabenazine 18 MG Extended Release Oral Tablet [Austedo]) / 7 (24 HR deutetrabenazine 24 MG Extended Release Oral Tablet [Austedo]) / 7 (24 HR deutetrabenazine 30 MG Extended Release Oral Tablet [Austedo]) } Pack [Austedo XR Once Daily, 4 Week Titration Pack, 12 MG / 18 MG / 24 MG / 30 MG] deutetrabenazine	3,659	72.2%	T4	99.6%	18,283
diflunisal 500 MG Oral Tablet diflunisal	3,659	72.2%	T2	0%	3,325
rivaroxaban 1 MG/ML Oral Suspension rivaroxaban	3,657	72.2%	T2	0.4%	1,324,165
methocarbamol 500 MG Oral Tablet methocarbamol	3,656	72.2%	T2	22.1%	1,036,252
methocarbamol 750 MG Oral Tablet methocarbamol	3,656	72.2%	T2	22.1%	1,036,252
{7 (ethinyl estradiol 0.01 MG Oral Tablet) / 84 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) } Pack [Ashlyna 91 Day] ethinyl estradiol	3,647	72%	T2	0%	-
0.5 ML ustekinumab-kfce 90 MG/ML Prefilled Syringe [Yesintek] ustekinumab-kfce	3,644	71.9%	T3	97.9%	-
0.5 ML ustekinumab-kfce 90 MG/ML Injection [Yesintek] ustekinumab-kfce	3,644	71.9%	T3	97.9%	-
sucralfate 100 MG/ML Oral Suspension sucralfate	3,642	71.9%	T3	0.6%	800,942
methotrexate 2 MG/ML Oral Solution [Jylamvo] methotrexate	3,641	71.9%	T3	83%	84
metoprolol tartrate 75 MG Oral Tablet metoprolol tartrate	3,634	71.7%	T1	0%	3,916,109
metoprolol tartrate 37.5 MG Oral Tablet metoprolol tartrate	3,629	71.6%	T1	0%	3,916,109
deferasirox 250 MG Tablet for Oral Suspension deferasirox	3,629	71.6%	T4	91.9%	3,436
naproxen sodium 275 MG Oral Tablet naproxen sodium	3,623	71.5%	T2	0%	39,316
deferasirox 125 MG Tablet for Oral Suspension deferasirox	3,622	71.5%	T3	91%	3,436
deferasirox 500 MG Tablet for Oral Suspension deferasirox	3,622	71.5%	T4	91.9%	3,436
{21 (ethinyl estradiol 0.035 MG / norethindrone 0.4 MG Chewable Tablet) / 7 (ferrous fumarate 75 MG Chewable Tablet) } Pack [Wymzya Fe 28 Day] ethinyl estradiol	3,618	71.4%	T3	0%	-
ceftazidime 1000 MG Injection [Tazicef] ceftazidime	3,617	71.4%	T3	9.2%	5,212
ceftazidime 2000 MG Injection [Tazicef] ceftazidime	3,612	71.3%	T3	9.2%	5,212
nitroglycerin 0.02 MG/MG Topical Ointment [Nitro-Bid] nitroglycerin	3,605	71.1%	T3	0%	1,348,161
erythromycin 20 MG/ML Medicated Pad [Ery] erythromycin	3,601	71.1%	T2	0%	1,861
24 HR mirabegron 8 MG/ML Extended Release Suspension [Myrbetriq] mirabegron	3,592	70.9%	T3	0%	769,978
lifitegrast 50 MG/ML Ophthalmic Solution [Xiidra] lifitegrast	3,583	70.7%	T3	14.9%	149,642
ceftazidime 200 MG/ML Injectable Solution [Tazicef] ceftazidime	3,578	70.6%	T3	9.3%	5,212
econazole nitrate 10 MG/ML Topical Cream econazole nitrate	3,577	70.6%	T2	0%	83,651
1 ML leuprolide acetate 7.5 MG/ML Prefilled Syringe [Lupron] leuprolide acetate	3,572	70.5%	T4	89.6%	-
{21 (memantine hydrochloride 10 MG Oral Tablet) / 28 (memantine hydrochloride 5 MG Oral Tablet) } Pack memantine hydrochloride	3,567	70.4%	T2	56.1%	-
potassium chloride 20 MEQ Powder for Oral Solution potassium chloride	3,563	70.3%	T3	0%	3,479,756
brinzolamide 10 MG/ML Ophthalmic Suspension brinzolamide	3,562	70.3%	T3	0%	43,939
lomustine 10 MG Oral Capsule [Gleostine] lomustine	3,560	70.3%	T3	10.1%	662
lomustine 40 MG Oral Capsule [Gleostine] lomustine	3,560	70.3%	T4	10.1%	662
lomustine 100 MG Oral Capsule [Gleostine] lomustine	3,560	70.3%	T4	10.1%	662
{28 (ethinyl estradiol 0.02 MG / levonorgestrel 0.09 MG Oral Tablet) } Pack [Dolishale 28 Day] ethinyl estradiol	3,547	70%	T2	0%	-
{28 (estradiol 0.5 MG / norethindrone acetate 0.1 MG Oral Tablet) } Pack [Abigale Lo 0.5/0.1 28 Day] estradiol	3,540	69.9%	T2	1.9%	-
{21 (ethinyl estradiol 0.035 MG / norethindrone 0.4 MG Chewable Tablet) / 7 (ferrous fumarate 75 MG Chewable Tablet) } Pack [Xelria Fe 28 Day] ethinyl estradiol	3,537	69.8%	T3	0%	-
NDA020983 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler [Ventolin] NDA020983	3,536	69.8%	T3	0%	-
24 HR tacrolimus 1 MG Extended Release Oral Tablet [Envarsus] tacrolimus	3,525	69.6%	T3	100%	-
24 HR tacrolimus 4 MG Extended Release Oral Tablet [Envarsus] tacrolimus	3,525	69.6%	T4	100%	-
24 HR tacrolimus 0.75 MG Extended Release Oral Tablet [Envarsus] tacrolimus	3,525	69.6%	T3	100%	-
guanfacine 1 MG Oral Tablet guanfacine	3,523	69.5%	T2	26.8%	22,464
guanfacine 2 MG Oral Tablet guanfacine	3,523	69.5%	T2	26.8%	22,464
ivermectin 6 MG Oral Tablet ivermectin	3,520	69.5%	T2	61.4%	40,953
sapropterin dihydrochloride 500 MG Powder for Oral Solution sapropterin dihydrochloride	3,518	69.4%	T4	95.7%	137
100 ML potassium chloride 0.2 MEQ/ML Injection potassium chloride	3,514	69.4%	T3	1.3%	-

← Previous Page 31 of 61 Next →

Source: CMS Quarterly Prescription Drug Plan Formulary PUF 2026. 6,046 drugs with RXCUI identifiers from NLM RxNorm. Coverage percentages based on 0 active Part D plans.

Compiled by Plainmedicare Editorial, Health Insurance Editorial Team